ARDT — Ardent Health Partners Income Statement
0.000.00%
- $1.79bn
- $2.72bn
- $5.97bn
- 92
- 91
- 33
- 84
Annual income statement for Ardent Health Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 4,870 | 5,130 | 5,409 | 5,966 |
Cost of Revenue | ||||
Gross Profit | 2,576 | 2,718 | 3,025 | 3,431 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 4,487 | 4,913 | 5,185 | 5,564 |
Operating Profit | 384 | 217 | 224 | 402 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 296 | 311 | 152 | 363 |
Provision for Income Taxes | ||||
Net Income After Taxes | 245 | 265 | 129 | 300 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 154 | 189 | 53.9 | 210 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 154 | 189 | 53.9 | 210 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.307 | 0.285 | 0.331 | 1.61 |